Similar articles for PMID: 23944295

Year	Number of Results
1986	1
1987	1
1990	1
1992	1
1993	1
1995	1
1996	3
1998	3
1999	2
2000	7
2001	2
2002	3
2003	3
2004	7
2005	3
2006	3
2007	4
2008	5
2009	6
2010	4
2011	3
2012	8
2013	7
2014	5
2015	11
2016	3
2017	7
2018	4
2019	3
2020	3
2021	3
2022	1
2024	0

1

The pharmacokinetics and pharmacodynamics of dehydroepiandrosterone during use of an ethinylestradiol- and drospirenone-containing oral contraceptive.

Zimmerman Y, Coelingh Bennink HJ, Wouters W, Ebes F, Fauser BC. Zimmerman Y, et al. Eur J Contracept Reprod Health Care. 2013 Dec;18(6):489-500. doi: 10.3109/13625187.2013.822061. Epub 2013 Aug 14. Eur J Contracept Reprod Health Care. 2013. PMID: 23944295 Clinical Trial.

2

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.

Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ. Zimmerman Y, et al. Contraception. 2015 Feb;91(2):127-33. doi: 10.1016/j.contraception.2014.11.002. Epub 2014 Nov 13. Contraception. 2015. PMID: 25604900 Clinical Trial.

3

The bioequivalence of the contraceptive steroids ethinylestradiol and drospirenone is not affected by co-administration of dehydroepiandrosterone.

Zimmerman Y, Wouters W, Coelingh Bennink HJ. Zimmerman Y, et al. Eur J Contracept Reprod Health Care. 2013 Jun;18(3):206-14. doi: 10.3109/13625187.2013.777831. Epub 2013 Apr 3. Eur J Contracept Reprod Health Care. 2013. PMID: 23550808 Clinical Trial.

4

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.

Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ. Zimmerman Y, et al. Contraception. 2015 Feb;91(2):134-42. doi: 10.1016/j.contraception.2014.11.008. Epub 2014 Nov 15. Contraception. 2015. PMID: 25496917 Clinical Trial.

5

Maintaining physiological testosterone levels by adding dehydroepiandrosterone to combined oral contraceptives: I. Endocrine effects.

Coelingh Bennink HJT, Zimmerman Y, Laan E, Termeer HMM, Appels N, Albert A, Fauser BCJM, Thijssen JHH, van Lunsen RHW. Coelingh Bennink HJT, et al. Contraception. 2017 Nov;96(5):322-329. doi: 10.1016/j.contraception.2016.06.022. Epub 2016 Jul 5. Contraception. 2017. PMID: 27393080 Free article. Clinical Trial.

6

Pituitary function and DHEA-S in male acne and DHEA-S, prolactin and cortisol before and after oral contraceptive treatment in female acne.

Palatsi R, Reinilä M, Kivinén S. Palatsi R, et al. Acta Derm Venereol. 1986;66(3):225-30. Acta Derm Venereol. 1986. PMID: 2426899 Clinical Trial.

7

Maintaining physiologic testosterone levels during combined oral contraceptives by adding dehydroepiandrosterone: II. Effects on sexual function. A phase II randomized, double-blind, placebo-controlled study.

van Lunsen RHW, Zimmerman Y, Coelingh Bennink HJT, Termeer HMM, Appels N, Fauser BCJM, Laan E. van Lunsen RHW, et al. Contraception. 2018 Jul;98(1):56-62. doi: 10.1016/j.contraception.2018.02.014. Epub 2018 Feb 25. Contraception. 2018. PMID: 29490289 Free article. Clinical Trial.

8

Effects of a combined oral contraceptive containing 20 mcg of ethinylestradiol and 3 mg of drospirenone on the blood pressure, renin-angiotensin-aldosterone system, insulin resistance, and androgenic profile of healthy young women.

Giribela CR, Consolim-Colombo FM, Nisenbaum MG, Moraes TL, Giribela AH, Baracat EC, Melo NR. Giribela CR, et al. Gynecol Endocrinol. 2015;31(11):912-5. doi: 10.3109/09513590.2015.1062860. Epub 2015 Jul 14. Gynecol Endocrinol. 2015. PMID: 26172927

9

Haemostatic and metabolic impact of estradiol pills and drospirenone-containing ethinylestradiol pills vs. levonorgestrel-containing ethinylestradiol pills: A literature review.

Lete I, Chabbert-Buffet N, Jamin C, Lello S, Lobo P, Nappi RE, Pintiaux A. Lete I, et al. Eur J Contracept Reprod Health Care. 2015;20(5):329-43. doi: 10.3109/13625187.2015.1050091. Epub 2015 May 26. Eur J Contracept Reprod Health Care. 2015. PMID: 26007631 Review.

10

Oral dehydroepiandrosterone for adrenal androgen replacement: pharmacokinetics and peripheral conversion to androgens and estrogens in young healthy females after dexamethasone suppression.

Arlt W, Justl HG, Callies F, Reincke M, Hübler D, Oettel M, Ernst M, Schulte HM, Allolio B. Arlt W, et al. J Clin Endocrinol Metab. 1998 Jun;83(6):1928-34. doi: 10.1210/jcem.83.6.4850. J Clin Endocrinol Metab. 1998. PMID: 9626121 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

110 results

Results by year